Hugel to Develop Next-generation Type E Botulinum Toxin Product

Posted By Madilyn Moeller, Thursday, May 9, 2024

Botox glabellar injection (drawn)

Hugel has started its development of new botulinum toxin products using a botulinum toxin type that has a faster onset and shorter duration of effect, the aesthetics firm said.

According to Hugel, botulinum neurotoxins that are currently used for therapeutic and cosmetic applications have been botulinum neurotoxin type A and B. The onset of action of botulinum toxin A, which is most widely used for cosmetic applications, ranges from three to seven days, while its therapeutic effect usually lasts around three six months.

On the other hand, the onset of botulinum neurotoxin type E’s clinical effect is within 24 hours, with a duration ranging from two to four weeks.

Read more at The Korea Herald >>